Skip to main content
Equibles

Michael Huang

Equibles does not estimate personal net worth.

About Michael Huang

Soleno Therapeutics Inc reported in an 8-K filed May 18, 2026 that Michael Huang resigned as Senior Vice President, Clinical Development, effective May 18, 2026.

“each of Anish Bhatnagar, M.D. (Chief Executive Officer), Jennifer Fulk (Chief Financial Officer), Patricia Hirano (Senior Vice President, Regulatory Affairs), Kristen Yen (Senior Vice President, Global Clinical Operations & Patient Advocacy), Meredith Manning (Chief Commercial Officer), Manher (AJ) Joshi (Chief Development Officer), Kevin Norrett (Chief Business Officer) and Michael Huang (Senior Vice President, Clinical Development) resigned from his or her positions as an officer of the Company, in each case, effective as of the Effective Time.”
Soleno Therapeutics Inc Form 8-K, filed May 18, 2026 · Read the filing

Affiliation history

  • Soleno Therapeutics Inc

    Proxy statement

    Start not stated–2026-05-18

Company network

Soleno Therapeutics Inc

Biotechnology · Healthcare

Recent activity